Glucose Metabolism in the Progression of Prostate Cancer

被引:107
作者
Cutruzzola, Francesca [1 ]
Giardina, Giorgio [1 ]
Marani, Marina [1 ]
Macone, Alberto [1 ]
Paiardini, Alessandro [2 ]
Rinaldo, Serena [1 ]
Paone, Alessio [1 ]
机构
[1] Sapienza Univ Rome, Dept Biochem Sci A Rossi Fanelli, Rome, Italy
[2] Sapienza Univ Roma, Dept Biol & Biotechnol Charles Darwin, Rome, Italy
关键词
prostate cancer; metabolism; microenvironment; Warburg effect; inflammation; BONE-MARROW; MITOCHONDRIAL ACONITASE; TUMOR-GROWTH; ZINC UPTAKE; KAPPA-B; CELLS; INFLAMMATION; ADIPOSE; ACID; FIBROBLASTS;
D O I
10.3389/fphys.2017.00097
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Prostate cancer is one of the most common types of cancer in western country males but the mechanisms involved in the transformation processes have not been clearly elucidated. Alteration in cellular metabolism in cancer cells is recognized as a hallmark of malignant transformation, although it is becoming clear that the biological features of metabolic reprogramming not only differ in different cancers, but also among different cells in a type of cancer. Normal prostate epithelial cells have a peculiar and very inefficient energy metabolism as they use glucose to synthesize citrate that is secreted as part of the seminal liquid. During the transformation process, prostate cancer cells modify their energy metabolism from inefficient to highly efficient, often taking advantage of the interaction with other cell types in the tumor microenvironment that are corrupted to produce and secrete metabolic intermediates used by cancer cells in catabolic and anabolic processes. We recapitulate the metabolic transformations occurring in the prostate from the normal cell to the metastasis, highlighting the role of the microenvironment and summarizing what is known on the molecular mechanisms involved in the process.
引用
收藏
页数:8
相关论文
共 50 条
[1]   ROLE OF CITRIC ACID IN PHYSIOLOGY OF PROSTATE .3. LACTATE/CITRATE RATIOS IN BENIGN + MALIGNANT PROSTATIC HOMOGENATES AS INDEX OF PROSTATIC MALIGNANCY [J].
COOPER, JF ;
FARID, I .
JOURNAL OF UROLOGY, 1964, 92 (05) :533-&
[2]   The intermediary metabolism of the prostate: A key to understanding the pathogenesis and progression of prostate malignancy [J].
Costello, LC ;
Franklin, RB .
ONCOLOGY, 2000, 59 (04) :269-282
[3]   Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells [J].
Costello, LC ;
Liu, YY ;
Franklin, RB ;
Kennedy, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :28875-28881
[4]   The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots [J].
Costello, Leslie C. ;
Franklin, Renty B. .
MOLECULAR CANCER, 2006, 5 (1)
[5]   Decreased zinc in the development and progression of malignancy: an important common relationship and potential for prevention and treatment of carcinomas [J].
Costello, Leslie C. ;
Franklin, Renty B. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (01) :51-66
[6]   Inflammation in prostate carcinogenesis [J].
De Marzo, Angelo M. ;
Platz, Elizabeth A. ;
Sutcliffe, Siobhan ;
Xu, Jianfeng ;
Gronberg, Henrik ;
Drake, Charles G. ;
Nakai, Yasutomo ;
Isaacs, William B. ;
Nelson, William G. .
NATURE REVIEWS CANCER, 2007, 7 (04) :256-269
[7]   Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis [J].
Dhup, Suveera ;
Dadhich, Rajesh Kumar ;
Porporato, Paolo Ettore ;
Sonveaux, Pierre .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (10) :1319-1330
[8]   Bone marrow adipocytes promote the warburg phenotype in metastatic prostate tumors via HIF-1a activation [J].
Diedrich, Jonathan D. ;
Rajagurubandara, Erandi ;
Herroon, Mackenzie K. ;
Mahapatra, Gargi ;
Huttemann, Maik ;
Podgorski, Izabela .
ONCOTARGET, 2016, 7 (40) :64854-64877
[9]   Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation [J].
Doldi, Valentina ;
Callari, Maurizio ;
Giannoni, Elisa ;
D'Aiuto, Francesca ;
Maffezzini, Massimo ;
Valdagni, Riccardo ;
Chiarugi, Paola ;
Gandellini, Paolo ;
Zaffaroni, Nadia .
ONCOTARGET, 2015, 6 (31) :31441-31460
[10]  
Elia I, 2016, HANDB EXP PHARMACOL, V233, P321, DOI 10.1007/164_2015_10